START Madrid - Hospital Universitario Fundación Jiménez Díaz

Madrid 28040

5 studies enrolling now · 7 studies all time

What they study most

Acute Myeloid Leukemia, Advanced Lung Carcinoma, Advanced Malignancies, Advanced Solid Tumors, HNSCC, KRAS G12C, Melanoma, Metastatic Lung Cancer, Metastatic Non-Small Cell Lung Cancer, Myelodysplastic Syndromes, NSCLC, Non-small Cell Lung Cancer

Studies at this site

• Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment — Recruiting now
• Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment — Recruiting now
• Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer — Recruiting now
• Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors — Recruiting now
• BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20) — Recruiting now
• A Study of DF6002 Alone and in Combination With Nivolumab — Completed
• Combination Study With Eftilagimod Alpha (a Soluble LAG-3 Fusion Protein) and Pembrolizumab in Patients With Recurrent or Metastatic HNSCC — Completed